id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-N-3445-0001,FDA,FDA-2026-N-3445,"Egis Pharmaceuticals Limited, et al.; Withdrawal of Approval of Three Abbreviated New Drug Applications",Notice,Withdrawal,2026-04-24T04:00:00Z,2026,4,2026-04-24T04:00:00Z,,2026-04-24T18:50:43Z,2026-08020,0,0,09000064b92a8517